ArticleJournal of the American Heart Association2022

Trimetazidine Alleviates Postresuscitation Myocardial Dysfunction and Improves 96-Hour Survival in a Ventricular Fibrillation Rat Model.

Jingru Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.